Please ensure Javascript is enabled for purposes of website accessibility
Cory Renauer

Cory Renauer

TMFang4apples

Cory is a long-term minded analyst focused on the Healthcare Sector. He genuinely enjoys cutting through the complexity to help everyday investors make better decisions.

Recent articles

brilliant-investment-advisor-showing-client-why-his-biotech-stock-is-higher

Why BioCryst Pharmaceuticals Rose 8% on Thursday

The company's first commercial drug launch keeps exceeding expectations.


investor-looking-at-stock-charts

Here's Why Ampio Pharmaceuticals Stock Is Surging Today

A positive second-quarter earnings report and anticipation of further details to be discussed this afternoon helped this beaten-down biotech stock recover some previous losses.


high-tech-healthcare-scene

3 Unstoppable Healthcare Stocks to Buy Now and Hold Forever

Here are some terrific options for investors who just want to set it and forget it.


Getty-Images-Well-Protected-Scientist

3 High-Growth Healthcare Stocks to Buy in August

These potential stock rockets are well worth the different risks they present.


scientists-working-in-lab-with-test-tubes-clipboard-getty

Here's Why TG Therapeutics Stock Is Getting Hammered Today

A second-quarter earnings report reminded investors how difficult it is for independent companies to launch new cancer drugs.

scientist-working-under-fume-hood

Here's Why Autolus Therapeutics Is Surging Today

Potential licensing agreements with Moderna are giving investors reasons to cheer.


cosmetic-dentistry

Is Align Technology a Buy After a Blowout Second Quarter?

The leading provider of clear aligners is firing on all cylinders right now.


scientists-working-in-lab

Here's Why Novocure Dipped 19% This Week

Uptake of the company's revolutionary disease-controlling device isn't progressing as quickly as expected.


nurse-senior-patient-hospital-bed-getty

Here's Why Annovis Bio, Anavex Life Sciences, and Cassava Sciences Sank on Thursday

A clinical-trial flop for Annovis Bio is reminding investors that developing new drugs for Alzheimer's disease is an extremely risky business.


investor-watching-stock-chart-rising-getty

Can Teladoc Health Stock Start Climbing Again?

Slowing growth in the face of exploding competition for digital health services should have investors more than a little concerned.

sales-rep-and-physician-getty

Here's Why Myovant Sciences Stock Is Falling Today

Second-quarter earnings results were a little bit disappointing.


scientist-examining-a-sample-tube

Here's Why Relmada Therapeutics Stock Popped Today

Results from a human abuse potential study with REL-1017 exceeded expectations.


angry-investor-getty

Here's Why NRx Pharmaceuticals Stock Dropped Monday

After soaring for a couple of days this popular COVID-19 stock fell back.


two-scientists-at-work-in-lab

2 Beaten-Down Biotech Stocks That Could Bounce Back

The market hasn't been kind to these two drugmakers, but both have a chance to turn things around.


scientists-at-work-in-laboratory

3 Biotech Stocks That Could Rocket Higher

Over the past year, these small-cap drugmakers have done well by their shareholders, and more big catalysts could be coming.

scientists-at-work-in-laboratory

Here's Why Alzamend Neuro Stock Is Shooting Higher Today

There's never been a better time to be a mouse with Alzheimer's disease.


scientist-presenting-to-investors-getty

Here's Why Cassava Sciences Is Surging Today

Investors are excited about upcoming presentations scheduled for the annual Alzheimer's Association International Conference.


sciency-scientists-with-lab-equipment-getty

3 Biotech Stocks That Could Double Soon

Wall Street analysts following these drugmakers think they can produce big gains in a short time frame.


excited-invetor-trading-stocks

Here's Why Cytokinetics Is Rocketing Higher Today

The company's new heart drug candidate produced encouraging clinical trial results.


smart-investor-drinking-coffee-and-buying-stocks

3 Stocks to Buy in the Upcoming Market Crash

Recurring revenue and network effects make these terrific stocks to buy on the dips.